Meta Health Limited (SG:5DX) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Meta Health Limited has expanded its stake in Jas Medical Screening Centre by acquiring 55% of its share capital. This acquisition involved the allotment of 23,331,000 Consideration Shares and 2,133,240 Initial Introducer Shares, increasing the company’s total issued shares to over 1 billion. The new shares are set to be listed on the Catalist of the SGX-ST, broadening Meta Health’s presence in the medical sector.
For further insights into SG:5DX stock, check out TipRanks’ Stock Analysis page.